Skip to main content

Table 1 Baseline characteristics of the patients

From: A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

Age (yrs)

52.9 ± 10.5*

Sex (no.)

 

 Male

15

 Female

7

Body-mass index (kg/m2)*

25.1 ± 2.4

Weight (kg)

70.5 ± 11.7

Glycated hemoglobin (%)

8.20 ± 1.69

Fasting plasma glucose (mmol/L)

7.53 ± 2.67

Fasting C-peptide (ng/mL)

1.29 ± 0.83

Diabetes duration (yrs)

8.7 ± 4.3

Smoking status (%)

4

Cholesterol (mmol/L)

 

Total

5.08 ± 0.84

HDL

1.08 ± 0.21

LDL

3.13 ± 0.72

TG

2.01 ± 1.63

Creatinine (μmol/L)

61.97 ± 19.93

Blood pressure (mm Hg)

 

Systolic

134.5 ± 10.3

Diastolic

85.75 ± 6.56

Use of antihypertensive medication (%)

4

History of cardiovascular disease (%)

2

Albumin excretion rate >30 mg/L/24 hr (%)

4

Retinopathy (%)

11

Antidiabetic treatment (%)

 

Oral drug

2

Insulin (alone or with oral drug)

17

  1. *Plus/minus values are means ± SD. The body mass index is the weight in kilograms divided by the square of the height in meters. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, total cholesterol.